We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-7.71%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.78M |
| 2 |
EOG Resources
EOG
|
+$1.78M |
| 3 |
ConocoPhillips
COP
|
+$1.72M |
| 4 |
Imperial Oil
IMO
|
+$1.64M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryman Hospitality Properties
RHP
|
+$2.57M |
| 2 |
Western Midstream Partners
WES
|
+$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
+$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
+$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
276
DELISTED
IGM Biosciences
IGMS
| $263K | 0.11% |
3,434
+60
| +2% | +$5.46K |
|
277
Kodiak Sciences
KOD
$2.5B
| $262K | 0.11% |
2,308
+40
| +2% | +$5.46K |
|
278
Arcus Biosciences
RCUS
$3.33B
| $262K | 0.11% |
9,348
+160
| +2% | +$5.57K |
|
279
Stellus Capital Investment Corp
SCM
$205M
| $260K | 0.11% |
20,469
+2,269
| +12% | +$26K |
|
|
FOLD
280
DELISTED
Amicus Therapeutics
FOLD
| $259K | 0.11% |
26,201
+714
| +3% | +$11.1K |
|
|
ALBO
281
DELISTED
Albireo Pharma Inc
ALBO
| $258K | 0.11% |
7,326
+134
| +2% | +$4.95K |
|
282
Fate Therapeutics
FATE
$275M
| $256K | 0.11% |
3,110
+49
| +2% | +$4.7K |
|
|
MYOV
283
DELISTED
Myovant Sciences Ltd.
MYOV
| $256K | 0.11% |
12,457
+221
| +2% | +$5.03K |
|
284
Regenxbio
RGNX
$616M
| $255K | 0.11% |
7,478
+139
| +2% | +$5.93K |
|
285
Phathom Pharmaceuticals
PHAT
$928M
| $254K | 0.11% |
6,753
+118
| +2% | +$4.94K |
|
|
RETA
286
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $253K | 0.11% |
2,537
+39
| +2% | +$4.55K |
|
287
Zentalis Pharmaceuticals
ZNTL
$332M
| $252K | 0.11% |
5,819
+108
| +2% | +$4.65K |
|
|
MRCC
288
DELISTED
Monroe Capital Corp
MRCC
| $250K | 0.11% |
24,915
-579
| -2% | -$5.32K |
|
289
Seres Therapeutics
MCRB
$45M
| $249K | 0.11% |
605
+10
| +2% | +$4.61K |
|
290
Mirum Pharmaceuticals
MIRM
$6.56B
| $248K | 0.1% |
12,515
+223
| +2% | +$4.27K |
|
|
APLS
291
DELISTED
Apellis Pharmaceuticals
APLS
| $247K | 0.1% |
5,761
+93
| +2% | +$4.4K |
|
292
Cogent Biosciences
COGT
$6.76B
| $247K | 0.1% |
+28,101
| New | +$271K |
|
293
CRISPR Therapeutics
CRSP
$4.69B
| $244K | 0.1% |
2,003
+37
| +2% | +$5.59K |
|
294
NextCure
NXTC
$20.4M
| $244K | 0.1% |
2,035
+36
| +2% | +$5.21K |
|
|
CCXI
295
DELISTED
ChemoCentryx, Inc.
CCXI
| $244K | 0.1% |
4,769
+75
| +2% | +$4.51K |
|
296
Rocket Pharmaceuticals
RCKT
$343M
| $238K | 0.1% |
5,361
+100
| +2% | +$5.49K |
|
|
KYNB
297
Kyntra Bio
KYNB
$27.4M
| $237K | 0.1% |
273
+4
| +1% | +$4.26K |
|
298
Relay Therapeutics
RLAY
$4B
| $237K | 0.1% |
6,849
+117
| +2% | +$5.08K |
|
299
Keros Therapeutics
KROS
$197M
| $236K | 0.1% |
3,835
+77
| +2% | +$4.88K |
|
300
Q32 Bio
QTTB
$435M
| $236K | 0.1% |
1,394
+25
| +2% | +$5.26K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.
Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.
- Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
- Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
- Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
- Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
- Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
- Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
- Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.
Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.